Becton Dickinson Insider Sale: Claire Fraser Disposes 917 BDX Shares

Rhea-AI Filing Summary

Claire Fraser, a director of Becton, Dickinson and Company (BDX), reported a sale of 917 shares of BDX common stock on 09/10/2025 at a reported price of $187.50 per share. After the sale, the reporting person beneficially owned 22,226 shares in a direct ownership form. The Form 4 was signed by Donna Kalazdy by power of attorney on 09/11/2025.

Insights

Corporate Governance Expert

TL;DR: Routine director sale, no additional context provided to indicate material governance concerns.

The filing documents a single non-derivative sale by a company director reducing direct holdings to 22,226 shares. The report identifies the seller as a director and shows the transaction was executed and reported via power of attorney. There is no accompanying disclosure about reasons for the sale, 10b5-1 plan, or related party transactions in the form, so the transaction appears routine based strictly on the data provided.

Securities Analyst

TL;DR: Materiality is low; the form records a straightforward insider disposition with clear price and quantity.

The Form 4 specifies the exact number of shares sold (917) and the execution price ($187.50), enabling precise calculation of proceeds from this transaction without additional assumptions. Because the filing shows a single sale and leaves the post-sale ownership level explicit, investors can update insider-holding records accurately. No derivatives, grants, or additional transactions are reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fraser Claire

(Last) (First) (Middle)

C/O BECTON, DICKINSON AND COMPANY

1 BECTON DRIVE

(Street)

FRANKLIN LAKES NJ 07417

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BECTON DICKINSON & CO [ BDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2025		S		917	D	$187.5	22,226	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Donna Kalazdy, by power of attorney for Claire Fraser	09/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Claire Fraser report on Form 4 for BDX?

The Form 4 reports a sale of 917 shares of BDX common stock on 09/10/2025 at $187.50 per share.

How many BDX shares does Claire Fraser own after the reported sale?

After the reported transaction, Claire Fraser beneficially owned 22,226 shares as a direct owner.

What is Claire Fraser's relationship to Becton, Dickinson and Company?

The filing indicates Claire Fraser is a Director of Becton, Dickinson and Company.

Who signed the Form 4 and when was it signed?

The Form 4 was signed by Donna Kalazdy, by power of attorney for Claire Fraser on 09/11/2025.

Does the Form 4 report any derivative transactions or grants?

No. Table II for derivative securities shows no entries; only a non-derivative common stock sale is reported.